Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination ...
A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...
SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback